Mesenteric excision surgery or conservative limited resection in Crohn's disease: study protocol for an international, multicenter, randomized controlled trial

Yi Li, Helen Mohan, Nan Lan, Xiaojian Wu, Wei Zhou, Jianfeng Gong, Bo Shen, Luca Stocchi, J Calvin Coffey, Weiming Zhu, Yi Li, Helen Mohan, Nan Lan, Xiaojian Wu, Wei Zhou, Jianfeng Gong, Bo Shen, Luca Stocchi, J Calvin Coffey, Weiming Zhu

Abstract

Background: The structures of the mesentery including adipose tissue, nerves, and lymphatics play an important role in the pathogenesis and disease progression of Crohn's disease (CD). Conventional surgical resection for CD usually does not involve resecting the mesentery en bloc with the specimen. This contrasts with complete mesocolic excision (CME) in colorectal cancer, which involves radical resection of the mesentery. Preliminary evidence from smaller studies suggests that applying the principle of mesocolic excision to CD surgery may reduce the risk of postoperative recurrence. This randomized controlled trial is designed to test whether applying the principles of mesocolic excision to CD results in reduced postoperative recurrence. It also aims to evaluate intra- and postoperative morbidity between the two approaches.

Methods: This international, multicenter, randomized controlled trial will randomize patients (n = 116) scheduled to undergo primary ileocolic resection to either receive extensive mesenteric excision (EME) or conventional ileocolic resection with limited mesenteric excision (LME). Five sites will recruit patients in three countries. In the EME group, the mesentery is resected following CME, while avoiding the root region, i.e., 1 cm from the root of the ileocolic artery and vein. In the LME group, the mesentery is retained, i.e., "close shave" or < 3 cm from the border of bowel. The primary end point will be surgical recurrence after surgery. The secondary end points will be the postoperative endoscopic and clinical recurrence, and intra- and postoperative morbidity. Demographics, risk factors, laboratory investigations, endoscopy, postoperative prophylaxis and imaging examination will be assessed. Analysis of the primary outcome will be on an intention-to-treat basis.

Discussion: If mesocolic excision in CD reduces postoperative disease recurrence and does not increase morbidity, this trial has the potential to change practice and reduce recurrence of CD after surgical resection.

Trial registration: Clinical Trials.gov, ID: NCT03769922. Registered on February 27, 2019.

Keywords: Crohn’s disease; Ileocolic resection; Mesentery; Postoperative recurrence.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Flow Diagram of schedule of enrollment, interventions, and assessments

References

    1. Risk factors for unfavourable postoperative outcome in patients with Crohn’s disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO. Colorectal Dis. 2017. 10.1111/codi.13889. [Epub ahead of print].
    1. Bressenot Aude, Peyrin-Biroulet Laurent. Histologic Features Predicting Postoperative Crohnʼs Disease Recurrence. Inflammatory Bowel Diseases. 2015;21(2):468–475. doi: 10.1097/MIB.0000000000000224.
    1. Li Y, Zhu W, Zuo L, Shen B. The role of the mesentery in Crohn’s disease: the contributions of nerves, vessels, lymphatics, and fat to the pathogenesis and disease course. Inflamm Bowel Dis. 2016;22(6):1483–95.
    1. Calvin Coffey J., Kiernan Miranda. Adipocyte-Epithelial Interactions and Crohn's Disease - An Emerging Drug Target. EBioMedicine. 2017;23:193–194. doi: 10.1016/j.ebiom.2017.08.029.
    1. Coffey JC, O’Leary DP, Kiernan MG, Faul P. The mesentery in Crohn’s disease: friend or foe? Curr Opin Gastroenterol. 2016;32(4):267–73.
    1. Li Y., Zhu W., Gong J., Zhang W., Gu L., Guo Z., Cao L., Shen B., Li N., Li J. Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease. Colorectal Disease. 2015;17(3):225–234. doi: 10.1111/codi.12798.
    1. Li Yi, Ge Yuanyuan, Gong Jianfeng, Zhu Weiming, Cao Lei, Guo Zhen, Gu Lili, Li Jieshou. Mesenteric Lymphatic Vessel Density Is Associated with Disease Behavior and Postoperative Recurrence in Crohn’s Disease. Journal of Gastrointestinal Surgery. 2018;22(12):2125–2132. doi: 10.1007/s11605-018-3884-9.
    1. Li Yi, Stocchi Luca, Liu Xiuli, Rui Yuanyi, Liu Ganglei, Remzi Feza H., Shen Bo. Presence of Granulomas in Mesenteric Lymph Nodes Is Associated with Postoperative Recurrence in Crohnʼs Disease. Inflammatory Bowel Diseases. 2015;21(11):2613–2618. doi: 10.1097/MIB.0000000000000541.
    1. Coffey Calvin J, Kiernan Miranda G, Sahebally Shaheel M, Jarrar Awad, Burke John P, Kiely Patrick A, Shen Bo, Waldron David, Peirce Colin, Moloney Manus, Skelly Maeve, Tibbitts Paul, Hidayat Hena, Faul Peter N, Healy Vourneen, O’Leary Peter D, Walsh Leon G, Dockery Peter, O’Connell Ronan P, Martin Sean T, Shanahan Fergus, Fiocchi Claudio, Dunne Colum P. Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated With Reduced Surgical Recurrence. Journal of Crohn's and Colitis. 2018;12(10):1139–1150. doi: 10.1093/ecco-jcc/jjx187.
    1. Coffey J Calvin, O'Leary D Peter. The mesentery: structure, function, and role in disease. The Lancet Gastroenterology & Hepatology. 2016;1(3):238–247. doi: 10.1016/S2468-1253(16)30026-7.
    1. Sehgal R., Coffey J. C. Historical development of mesenteric anatomy provides a universally applicable anatomic paradigm for complete/total mesocolic excision. Gastroenterology Report. 2014;2(4):245–250. doi: 10.1093/gastro/gou046.
    1. Culligan Kevin, Walsh Stewart, Dunne Colum, Walsh Michael, Ryan Siobhan, Quondamatteo Fabio, Dockery Peter, Coffey J. Calvin. The Mesocolon. Annals of Surgery. 2014;260(6):1048–1056. doi: 10.1097/SLA.0000000000000323.
    1. Probst Pascal, Zaschke Steffen, Heger Patrick, Harnoss Julian C., Hüttner Felix J., Mihaljevic André L., Knebel Phillip, Diener Markus K. Evidence-based recommendations for blinding in surgical trials. Langenbeck's Archives of Surgery. 2019;404(3):273–284. doi: 10.1007/s00423-019-01761-6.
    1. Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ, Sebastian S, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease. Part 2: Surgical management and special situations. J Crohns Colitis. 2016;11(2):135–149. doi: 10.1093/ecco-jcc/jjw169.
    1. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99(4):956–963. doi: 10.1016/0016-5085(90)90613-6.
    1. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi: 10.1097/SLA.0b013e3181b13ca2.
    1. Best WR, Becktel JM, Singleton JW, Kern F., Jr Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70(3):439–444. doi: 10.1016/S0016-5085(76)80163-1.
    1. Maguire Lillias Holmes, Alavi Karim, Sudan Ranjan, Wise Paul E., Kaiser Andreas M., Bordeianou Liliana. Surgical Considerations in the Treatment of Small Bowel Crohn’s Disease. Journal of Gastrointestinal Surgery. 2016;21(2):398–411. doi: 10.1007/s11605-016-3330-9.
    1. Bergman L, Krause U. Crohn’s disease. A long-term study of the clinical course in 186 patients. Scand J Gastroenterol. 1977;12(8):937–944. doi: 10.3109/00365527709181353.
    1. Fazio VW, Marchetti F, Church M, Goldblum JR, Lavery C, Hull TL, Milsom JW, Strong SA, Oakley JR, Secic M. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg. 1996;224(4):563–571. doi: 10.1097/00000658-199610000-00014.
    1. Pennington L, Hamilton SR, Bayless TM, Cameron JL. Surgical management of Crohn’s disease. Influence of disease at margin of resection. Ann Surg. 1980;192(3):311–318. doi: 10.1097/00000658-198009000-00006.
    1. Kiernan Miranda G, Coffey J Calvin, McDermott Kieran, Cotter Paul D, Cabrera-Rubio Raul, Kiely Patrick A, Dunne Colum P. The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn’s Disease and Ulcerative Colitis. Journal of Crohn's and Colitis. 2018;13(1):58–66. doi: 10.1093/ecco-jcc/jjy136.
    1. Feng Yun, Li Yi, Mei Shuqin, Zhang Liang, Gong Jianfeng, Gu Lili, Zhang Wei, Zhu Weiming, Li Ning, Li Jieshou. Exclusive enteral nutrition ameliorates mesenteric adipose tissue alterations in patients with active Crohn's disease. Clinical Nutrition. 2014;33(5):850–858. doi: 10.1016/j.clnu.2013.10.009.
    1. Ge Yuanyuan, Li Yi, Gong Jianfeng, Zhu Weiming. Mesenteric organ lymphatics and inflammatory bowel disease. Annals of Anatomy - Anatomischer Anzeiger. 2018;218:199–204. doi: 10.1016/j.aanat.2018.03.006.
    1. Holt D. Q., Moore G. T., Strauss B. J. G., Hamilton A. L., De Cruz P., Kamm M. A. Visceral adiposity predicts post-operative Crohn's disease recurrence. Alimentary Pharmacology & Therapeutics. 2017;45(9):1255–1264. doi: 10.1111/apt.14018.
    1. Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V. Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn’s disease. Clin Gastroenterol Hepatol. 2011;9(8):684–687.e681. doi: 10.1016/j.cgh.2011.05.005.
    1. Maconi G, Greco S, Duca P, Ardizzone S, Massari A, Cassinotti A, Radice E, Porro GB. Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn’s disease. Inflamm Bowel Dis. 2008;14(11):1555–1561. doi: 10.1002/ibd.20515.
    1. Colombel JF, Solem CA, Sandborn WJ, Booya F, Loftus EV, Jr, Harmsen WS, Zinsmeister AR, Bodily KD, Fletcher JG. Quantitative measurement and visual assessment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut. 2006;55(11):1561–1567. doi: 10.1136/gut.2005.084301.
    1. Sheehan AL, Warren BF, Gear MW, Shepherd NA. Fat-wrapping in Crohn’s disease: pathological basis and relevance to surgical practice. Br J Surg. 1992;79(9):955–958. doi: 10.1002/bjs.1800790934.
    1. Shen Weisong, Li Yi, Cao Lei, Cai Xingchen, Ge Yuanyuan, Zhu Weiming. Decreased Expression of Prox1 Is Associated With Postoperative Recurrence in Crohn’s Disease. Journal of Crohn's and Colitis. 2018;12(10):1210–1218. doi: 10.1093/ecco-jcc/jjy091.
    1. Sahebally S. M., Burke J. P., Chang K. H., Kiernan M. G., O'Connell P. R., Coffey J. C. Circulating fibrocytes and Crohn's disease. British Journal of Surgery. 2013;100(12):1549–1556. doi: 10.1002/bjs.9302.
    1. Buskens Christianne J, Bemelman Willem A. Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated with Reduced Surgical Recurrence. Journal of Crohn's and Colitis. 2018;12(10):1137–1138. doi: 10.1093/ecco-jcc/jjy115.
    1. Shen Weisong, Li Yi, Zou Yujie, Cao Lei, Cai Xingchen, Gong Jianfeng, Xu Yihan, Zhu Weiming. Mesenteric Adipose Tissue Alterations in Crohn’s Disease Are Associated With the Lymphatic System. Inflammatory Bowel Diseases. 2018;25(2):283–293. doi: 10.1093/ibd/izy306.
    1. Dickerson Lindsay K., De Freitas Simon, Pozo Marcos E., Safar Bashar. Letter to the Editor: Mesenteric Lymphatic Vessel Density Is Associated with Disease Behavior and Postoperative Recurrence in Crohn’s Disease. Journal of Gastrointestinal Surgery. 2018;23(1):181–182. doi: 10.1007/s11605-018-3987-3.
    1. Peltrini Roberto, Bucci L. “Mesentery-based surgery” to prevent surgical recurrence in Crohn’s disease: from basics to surgical practice. International Journal of Colorectal Disease. 2018;34(2):353–354. doi: 10.1007/s00384-018-3197-1.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する